FDA Issues Warning Against Using Cue Health COVID Tests
The FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MorePosted by Andy Lundin | May 14, 2024 | Covid 19 |
The FDA warned against using Cue Health’s COVID tests due to modifications that reduced test reliability and increased risk of false results.
Read MorePosted by Unassigned Content | Apr 23, 2024 | Coagulation Testing, Webcasts |
Join our webinar to learn how aligning clinical and laboratory practices using the Quantra Hemostasis System can dramatically improve management of critical bleeding. Gain insights on viscoelastic testing, rapid identification of acute coagulopathy, and effective team collaboration. Perfect for technicians, lab managers, and healthcare providers.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Sexually Transmitted Diseases |
Scout received funding to develop a test to detect and differentiate between Neisseria gonorrhoeae and Chlamydia trachomatis quickly.
Read MorePosted by Andy Lundin | Apr 5, 2024 | Coagulation Testing |
Haemonetics received 510(k) clearance from the U.S. FDA for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge.
Read MorePosted by Andy Lundin | Apr 5, 2024 | Cardiovascular |
Analytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read More